Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to baseline risk in PARADIGM-HF

被引：0
|
作者：
Simpson, J. [1 ]
Squire, I. B. [2 ]
Martinez, F. [3 ]
Rouleau, J. L. [4 ]
Swedberg, K. [5 ]
Zile, M. [6 ]
Lefkowitz, M. [7 ]
Packer, M. [8 ]
Mcmurray, J. J. V. [1 ]
Solomon, S. D. [9 ]
机构：
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[2] NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England
[3] Univ Nacl Cordoba, Med Interna, Inst DAMIC, Fdn Rusculleda, RA-5000 Cordoba, Argentina
[4] Univ Montreal, Montreal, PQ, Canada
[5] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden
[6] Med Univ S Carolina, Charleston, SC 29425 USA
[7] Novartis Pharmaceut, Hanover, NH USA
[8] Univ Texas Southwestern Med Sch, Dallas, TX USA
[9] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1416
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [1] Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to age in PARADIGM-HF
    Mcmurray, J. J. V.
    Jhund, P. S.
    Fu, M.
    Katova, T.
    Rouleau, J. L.
    Solomon, S. D.
    Swedberg, K.
    Zile, M.
    Salko, M.
    Packer, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 143 - 143
  • [2] Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to systolic blood pressure in PARADIGM-HF
    Bohm, M.
    Refsgaard, J.
    Ramires, F. J. A.
    Rouleau, J. L.
    Solomon, S. D.
    Swedberg, K.
    Zile, M.
    Shi, V. C.
    Packer, M.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 393 - 393
  • [3] Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
    Desai, Akshay S.
    McMurray, John J. V.
    Packer, Milton
    Swedberg, Karl
    Rouleau, Jean L.
    Chen, Fabian
    Gong, Jianjian
    Rizkala, Adel R.
    Brahimi, Abdel
    Claggett, Brian
    Finn, Peter V.
    Hartley, Loren Howard
    Liu, Jiankang
    Lefkowitz, Martin
    Shi, Victor
    Zile, Michael R.
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2015, 36 (30) : 1990 - 1997
  • [4] Comparison of the Baseline Demographics of the LCZ696 PARADIGM-HF and TITRATION Studies
    Chen, Fabian
    Charney, Alan
    Gong, Jim
    Shi, Victor
    Senni, Michele
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S45
  • [5] Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor
    Gan, Lu
    Langenickel, Thomas
    Petruck, Jesika
    Kode, Kiran
    Rajman, Iris
    Chandra, Priya
    Zhou, Wei
    Rebello, Sam
    Sunkara, Gangadhar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (01): : 78 - 86
  • [6] Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores
    Simpson, Joanne
    Jhund, Pardeep S.
    Cardoso, Jose Silva
    Martinez, Felipe
    Mosterd, Arend
    Ramires, Felix
    Rizkala, Adel R.
    Senni, Michele
    Squire, Iain
    Gong, Jianjian
    Lefkowitz, Martin P.
    Shi, Victor C.
    Desai, Akshay S.
    Rouleau, Jean L.
    Swedberg, Karl
    Zile, Michael R.
    McMurray, John J. V.
    Packer, Milton
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2059 - 2071
  • [7] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Ayalasomayajula, Surya P.
    Langenickel, Thomas H.
    Jordaan, Pierre
    Zhou, Wei
    Chandra, Priyamvada
    Albrecht, Diego
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (09) : 1065 - 1073
  • [8] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Surya P. Ayalasomayajula
    Thomas H. Langenickel
    Pierre Jordaan
    Wei Zhou
    Priyamvada Chandra
    Diego Albrecht
    Parasar Pal
    Iris Rajman
    Gangadhar Sunkara
    European Journal of Clinical Pharmacology, 2016, 72 : 1065 - 1073
  • [9] Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
    Shi, Victor
    Senni, Michele
    Streefkerk, Hendrik
    Modgill, Vikas
    Zhou, Wenchun
    Kaplan, Allen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 118 - 123
  • [10] Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?
    Katsi, Vasiliki
    Skalis, Georgios
    Pavlidis, Antonis N.
    Makris, Thomas
    Nihoyannopoulos, Petros
    Tousoulis, Dimitris
    Kallikazaros, Ioannis
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (04) : 260 - 264
12345